AAAP: GOOD NEWS FOR TREATMENT OF THE CANCER THAT KILLED STEVE JOBS OF APPLE $AAPL $AAAP $NVS
This post was just published on ZYX Buy Change Alert. Advanced Accelerator Applications (AAAP) stock is long from $40.50. As of this writing it is trading at $66.65. AAAP’s lutetium, the treatment for the cancer that killed Steve Jobs of Apple (AAPL), has been approved by the European Commission. This good news is